The House Ways and Means Committee has advanced two bills that would change what Medicare covers, though neither is law. H.R. 6130 would create a Medicare pathway for FDA-approved blood-based Alzheimer’s screening tests, and H.R. 5439 would run a six-year Medicare pilot of medically tailored meals after hospitalization. The committee’s release says the meals approach reduced per-person costs by $3,400, a figure that comes from studies the committee cites rather than from a budget score.
H.R. 6130 would build a payment route for blood-based Alzheimer’s screening
According to the committee’s Sept. 18 release, H.R. 6130, the Alzheimer’s Screening and Prevention Act, cleared the committee 40-0. The release says new blood tests can identify the disease in its early stages, before mild cognitive impairment develops, and that Medicare currently lacks a pathway to cover such screening technologies. The bill would provide transitional Medicare reimbursement for screening tests that the Food and Drug Administration has approved.
The bill is a proposal about payment, not a coverage decision. The release does not say which test a patient could receive, how often, or what a beneficiary would owe, and it states no cost-sharing terms.
What Medicare pays for today is narrower. Medicare.gov says Part B covers a separate visit to review cognitive function and develop a care plan for conditions such as dementia and Alzheimer’s disease. After the Part B deductible, the patient pays 20% of the Medicare-approved amount, and a cognitive assessment may also be done at a yearly wellness visit at no separate charge. That existing benefit is a clinical assessment and care-planning visit, and the committee’s release describes the missing piece as a route for blood-based screening tests specifically.
H.R. 5439 would test medically tailored meals for six years
H.R. 5439, the Medically Tailored Home-Delivered Meals Program Pilot Act, cleared the committee 39-0, the release says. It would create a six-year Medicare pilot providing specially designed meals to beneficiaries with diet-related chronic conditions after hospitalization.
The committee’s release supports the proposal with several figures. It says over two-thirds of Medicare beneficiaries are overweight or obese, that Medicare has the highest 30-day readmission rate among payers at an average of more than $15,000 per readmission, and that studies show patients receiving medically tailored meals had 30% fewer hospitalizations and 20% fewer emergency department visits. It adds that per-person health care costs decreased by $3,400. Those are the committee’s own characterizations of research, offered in support of the bill, and they are attributed to studies rather than to a Congressional Budget Office score.
The release places the $3,400 next to the readmission cost of more than $15,000, which frames the pilot as a way to reduce hospital spending. It does not say how much of any saving would reach beneficiaries, whose costs under Original Medicare or a Medicare Advantage plan are set by separate rules, and a per-patient reduction in program spending is not the same thing as $3,400 back to the patient.
The dollar stakes for a beneficiary today are different. Medicare.gov’s home health coverage page lists home meal delivery among the items Original Medicare does not cover, so a patient leaving the hospital who needs meal delivery arranges and pays for it independently. KFF notes that Medicare Advantage plans can offer extras such as meal delivery services, with coverage varying by plan and location and some extras carrying an added monthly premium.
A committee vote is one step, not a benefit
The Ways and Means Committee’s markup page lists the meeting as Sept. 16, 2026, with seven bills under consideration: H.R. 10357, H.R. 10334, H.R. 6130, H.R. 5439, H.R. 4093, H.R. 10346 and H.R. 10356. The release announcing the votes came two days later, and because the markup page lists only bill numbers and the meeting details, without titles or outcomes, the vote tallies here rest on that release. Committee Chairman Jason Smith of Missouri said the bills would help “improve health outcomes in our country and make care more affordable.”
The unanimous tallies signal bipartisan support in committee, but they leave the bills where all committee-approved bills sit: awaiting further action. No Medicare benefit changes when a committee reports a bill, and nothing in the release gives a start date for either the screening coverage or the meals pilot. Any coverage would depend on the bills becoming law, and then on Medicare implementing them.
The release leaves practical questions unanswered for both bills, including which tests would qualify, which patients would be eligible for the pilot, and which regions or plans would take part. Readers who track the bills should treat the $3,400 as a claim the committee makes about past studies, and any change in what Medicare pays as something that has not been enacted.
The Sept. 18 release remains the primary record of the committee’s action, and it identifies both measures as advancing from committee, not as passed by the House.
Medicare coverage denials and the appeal record
Medicare beneficiaries who receive a prior-authorization or coverage denial have appeal rights, but the steps and paperwork are easy to lose track of.
The Medicare Cost & Coverage Protection Kit includes the prior-authorization appeal steps and a medication and cost tracker, which organize a denial appeal and follow drug spending over the year.
Grab The Medicare Cost & Coverage Protection Kit →
This article was produced with AI assistance and checked against the primary sources linked above.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
